8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Apr 20, 2011)

Filed April 20, 2011For Securities:EW

Summary

Edwards Lifesciences Corporation (EW) filed an 8-K report on April 20, 2011, to announce its financial results for the first quarter of 2011. The key takeaway for investors is the release of this quarterly earnings information, which provides insights into the company's performance and financial condition during the period. The press release containing these detailed results is attached as an exhibit to this filing. Investors should review the attached press release (Exhibit 99.1) for specific figures related to revenue, profitability, and any forward-looking guidance or commentary from the company's management. This filing serves as a formal notification of the company's Q1 2011 financial outcomes.

Key Highlights

  • 1Edwards Lifesciences filed an 8-K on April 20, 2011, reporting its Q1 2011 financial results.
  • 2The primary purpose of the filing is to disclose the company's financial performance for the first quarter of 2011.
  • 3A press release containing the detailed Q1 2011 financial results is attached as Exhibit 99.1.
  • 4The filing confirms the date of the earnings announcement was April 20, 2011.
  • 5The report is signed by Thomas M. Abate, Corporate Vice President and Chief Financial Officer.
  • 6This 8-K specifically addresses Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce and disclose Edwards Lifesciences Corporation's financial results for the first quarter of 2011 to the public and regulatory bodies.

The specific financial results for Q1 2011 are detailed in the press release attached as Exhibit 99.1 to this 8-K filing.

The filing was signed by Thomas M. Abate, who holds the position of Corporate Vice President and Chief Financial Officer at Edwards Lifesciences Corporation.

This 8-K filing itself primarily serves to report past results. Any forward-looking statements or guidance would be contained within the attached press release (Exhibit 99.1), which investors should consult for such information.